Trial
NCT02457286
Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Northwell Health
Collaborators
—
Condition
Non-alcoholic Fatty Liver Disease (NAFLD)
Intervention
Metformin
Why stopped
patients do not want to participate
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-07-28